JP2009531288A5 - - Google Patents

Download PDF

Info

Publication number
JP2009531288A5
JP2009531288A5 JP2008554515A JP2008554515A JP2009531288A5 JP 2009531288 A5 JP2009531288 A5 JP 2009531288A5 JP 2008554515 A JP2008554515 A JP 2008554515A JP 2008554515 A JP2008554515 A JP 2008554515A JP 2009531288 A5 JP2009531288 A5 JP 2009531288A5
Authority
JP
Japan
Prior art keywords
carbon atoms
compound
formula
alkyl
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008554515A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009531288A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/061908 external-priority patent/WO2007095462A2/en
Publication of JP2009531288A publication Critical patent/JP2009531288A/ja
Publication of JP2009531288A5 publication Critical patent/JP2009531288A5/ja
Pending legal-status Critical Current

Links

JP2008554515A 2006-02-13 2007-02-09 代謝障害の処置のための化合物 Pending JP2009531288A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77268706P 2006-02-13 2006-02-13
PCT/US2007/061908 WO2007095462A2 (en) 2006-02-13 2007-02-09 Compounds for the treatment of metabolic disorders

Publications (2)

Publication Number Publication Date
JP2009531288A JP2009531288A (ja) 2009-09-03
JP2009531288A5 true JP2009531288A5 (enExample) 2011-02-10

Family

ID=38372188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008554515A Pending JP2009531288A (ja) 2006-02-13 2007-02-09 代謝障害の処置のための化合物

Country Status (5)

Country Link
US (1) US8044243B2 (enExample)
EP (1) EP1983972A4 (enExample)
JP (1) JP2009531288A (enExample)
CA (1) CA2637884A1 (enExample)
WO (1) WO2007095462A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2266946A3 (en) * 2003-02-13 2012-12-12 Wellstat Therapeutics Corporation Compound For The Treatment Of Metabolic Disorders
EP1978948A4 (en) * 2006-02-02 2010-06-16 Wellstat Therapeutics Corp COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US8481595B2 (en) * 2008-01-15 2013-07-09 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
DE102010015123A1 (de) 2010-04-16 2011-10-20 Sanofi-Aventis Deutschland Gmbh Benzylamidische Diphenylazetidinone, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
KR102180485B1 (ko) 2012-04-12 2020-11-18 버지니아 커먼웰스 유니버시티 대사 장애, 고지질혈증, 당뇨병, 지방간 질환 및 죽상동맥경화증의 치료를 위한 신규한 콜레스테롤 대사물질, 5-콜레스텐-3β,25-디올, 디설페이트 (２５ＨＣＤＳ)
EA034524B1 (ru) 2014-10-10 2020-02-17 Вирджиния Коммонвелт Юниверсити Сульфаты окисленного холестерина для лечения пониженной лептиновой активности
KR102462275B1 (ko) 2016-08-02 2022-11-01 듀렉트 코퍼레이션 산소화 콜레스테롤 술페이트, 및 폴리알킬렌 글리콜, 카르복시메틸 셀룰로오스 및 폴리옥실글리세리드 중 적어도 하나를 포함하는 조성물
WO2018026781A1 (en) 2016-08-02 2018-02-08 Virginia Commonwealth University Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2249309B (en) * 1990-10-25 1995-03-22 Merck Patent Gmbh Polyfluorobiphenyls
JP3498853B2 (ja) * 1993-09-27 2004-02-23 小野薬品工業株式会社 ビフェニル誘導体
EP0875562A4 (en) * 1996-10-22 2004-11-17 Daicel Chem NEW SECONDARY ALCOHOLDEHYDROGENASE, PRODUCTION PROCESS FOR THE ENZYME AND FOR ALCOHOLS AND KETONES
US6232322B1 (en) * 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
DE19830770C1 (de) * 1998-07-09 2000-05-18 Sueddeutsche Kalkstickstoff Wasserlösliche Zinkpyruvate bzw. deren Hydrate, Verfahren zu ihrer Herstellung und deren Verwendung
JP4048721B2 (ja) * 2001-03-13 2008-02-20 セイコーエプソン株式会社 分散媒
CZ20033394A3 (cs) * 2001-06-12 2005-03-16 Wellstat Therapeutics Corporation Sloučeniny pro léčení metabolických poruch a způsob jejich přípravy
AU2003286728A1 (en) * 2002-11-01 2004-06-07 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
EP2266946A3 (en) * 2003-02-13 2012-12-12 Wellstat Therapeutics Corporation Compound For The Treatment Of Metabolic Disorders
DE602004030004D1 (de) * 2003-04-15 2010-12-23 Wellstat Therapeutics Corp Verbindungen zur behandlung von stoffwechselstörungen
US7361686B2 (en) * 2003-04-22 2008-04-22 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
EP1617835B1 (en) * 2003-04-30 2011-09-28 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
CN1835743A (zh) * 2003-08-20 2006-09-20 维尔斯达医疗公司 用于治疗代谢紊乱的化合物

Similar Documents

Publication Publication Date Title
JP2009531288A5 (enExample)
US8044243B2 (en) Compounds for the treatment of metabolic disorders
JP2009537559A (ja) 代謝障害の処置のための化合物
JP2009531280A (ja) 代謝障害を処置するための化合物
JP2009528375A (ja) 代謝障害を処置するための化合物
JP4837557B2 (ja) 代謝障害の処置のための化合物
JP5240927B2 (ja) 代謝障害の処置のための化合物
US7947735B2 (en) Compounds for the treatment of metabolic disorders
US7645772B2 (en) Treatment of metabolic disorders
JP4697973B2 (ja) 代謝障害の処置のための化合物
JP2006523696A (ja) 代謝障害の処置のための化合物
JP4703563B2 (ja) 代謝障害を治療するための化合物
JP5252585B2 (ja) 代謝障害の治療のための化合物
JP2009524686A (ja) 代謝障害を処置するための化合物
JP2009525982A (ja) 代謝障害の治療のための化合物
MX2008009595A (es) Compuestos para el tratamiento de trastornos metabolicos